Filing Details

Accession Number:
0000899243-18-029950
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-03 16:30:36
Reporting Period:
2018-11-29
Accepted Time:
2018-12-03 16:30:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610664 Cesare Orlandi C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-11-29 1,797 $18.00 86,064 No 4 S Direct
Common Stock Disposition 2018-11-29 400 $18.01 85,664 No 4 S Direct
Common Stock Disposition 2018-11-30 800 $18.00 84,864 No 4 S Direct
Common Stock Disposition 2018-11-30 4,058 $18.02 80,806 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2018.